101140.KS

INBIOGEN CO.,Ltd [101140.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

101140.KS Stock Summary

In the News

101140.KS Financial details

Company Rating
Buy
Market Cap
4.67B
Income
20.29B
Revenue
7.92B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
2.27
Forward P/E
-
PEG
-0.28
P/S
0.59
P/B
0.31
P/C
-
P/FCF
-0.5
Quick Ratio
-
Current Ratio
5.91
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
319.17
EPS next Y
-
EPS next Q
-
EPS this Y
-194.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
8.55%
Revenue Q/Q
-34.65%
EPS Q/Q
188.61%
-
-
-
-
SMA20
-
SMA50
-
SMA100
1900%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
16%
ROC
0.27%
Gross Margin
23%
Oper. Margin
517%
Profit Margin
256%
Payout
-
Shs Outstand
9.99M
Shs Float
842.35K
-
-
-
-
Target Price
-
52W Range
462.0-2650.0
52W High
+252.45%
52W Low
+1921.65%
RSI
100
Rel Volume
-
Avg Volume
271.77K
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
1900%
Perf Half Y
1900%
-
-
-
-
Beta
1.032
-
-
Volatility
0%, 0%
Prev Close
0%
Price
9340
Change
0%

101140.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
329.99306.01247.07195.2157.25
Net income per share
72.58850.81-1.09K1.75K-1.65K
Operating cash flow per share
-74.09-119.59-194.24-131.66-158.65
Free cash flow per share
-74.09-132.58-217.72-176.39-163.21
Cash per share
908.35876.061.91K431.18128.1
Book value per share
1.02K2.06K1.88K3.32K1.44K
Tangible book value per share
1.02K2.06K1.87K3.31K1.43K
Share holders equity per share
1.02K2.06K1.88K3.32K1.44K
Interest debt per share
0441.81266.09321.0875.36
Market cap
117.39B95.55B216.7B191.15B56.56B
Enterprise value
116.78B97.39B212.36B181.41B49.05B
P/E ratio
70.553.51-4.812.03-0.47
Price to sales ratio
15.529.7521.2118.244.96
POCF ratio
-69.1-24.96-26.98-27.04-4.92
PFCF ratio
-69.1-22.51-24.07-20.18-4.78
P/B Ratio
5.031.452.781.070.54
PTB ratio
5.031.452.781.070.54
EV to sales
15.439.9420.7817.314.3
Enterprise value over EBITDA
77.25-133.16-8.54-47.181.08
EV to operating cash flow
-68.74-25.44-26.44-25.66-4.26
EV to free cash flow
-68.74-22.95-23.59-19.15-4.14
Earnings yield
0.010.29-0.210.49-2.12
Free cash flow yield
-0.01-0.04-0.04-0.05-0.21
Debt to equity
00.150.060.080.02
Debt to assets
00.110.050.050.01
Net debt to EBITDA
-0.41-2.510.172.53-0.17
Current ratio
37.651.344.730.410.47
Interest coverage
0-0.5-0.87-2.0111.93
Income quality
-1.02-0.290.18-0.080.1
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.010.020.040.10.16
Research and developement to revenue
00000
Intangibles to total assets
000.0100
Capex to operating cash flow
00.110.120.340.03
Capex to revenue
0-0.04-0.1-0.23-0.03
Capex to depreciation
0-1.63-2.19-2.15-0.23
Stock based compensation to revenue
00000
Graham number
1.29K6.28K6.8K11.44K7.31K
ROIC
0.07-0.06-0.06-0.030.36
Return on tangible assets
0.070.3-0.470.34-0.85
Graham Net
903.78189.61.57K-1.25K-316.94
Working capital
23.32B8.38B67.71B-45.87B-19.33B
Tangible asset value
23.35B65.87B77.37B177.56B103.9B
Net current asset value
22.99B7.76B66.87B-64.55B-20.37B
Invested capital
00.150.060.080.02
Average receivables
01.26B4.16B6.37B6.38B
Average payables
603.97M430.04M495.87M602.43M477.46M
Average inventory
1.4B1.93B1.57B1.25B1.51B
Days sales outstanding
093.65207.17241.87186.08
Days payables outstanding
23.0718.1221.6827.6712.75
Days of inventory on hand
93.3189.0939.3363.4763.25
Receivables turnover
03.91.761.511.96
Payables turnover
15.8220.1516.8313.1928.63
Inventory turnover
3.914.19.285.755.77
ROE
0.070.41-0.580.53-1.15
Capex per share
0-13-23.48-44.73-4.56

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
34.9234.1928.8513.380
Net income per share
-96.13-58.93269.29280
Operating cash flow per share
-7.65-106-7.14-3.220
Free cash flow per share
-8.63-106.31-7.14-3.220
Cash per share
113.87128.1120.1143.860
Book value per share
595.331.44K1.64K981.920
Tangible book value per share
587.771.43K1.64K979.070
Share holders equity per share
595.331.44K1.64K981.920
Interest debt per share
108.8732.728.185.40
Market cap
91.58B56.56B33.87B70.57B0
Enterprise value
90.19B49.05B27.04B64.68B0
P/E ratio
-3.26-3.310.434.170
Price to sales ratio
35.9422.8216.1934.890
POCF ratio
-164.14-7.36-65.43-144.840
PFCF ratio
-145.34-7.34-65.43-144.840
P/B Ratio
2.110.540.280.480
PTB ratio
2.110.540.280.480
EV to sales
35.419.7812.9231.980
Enterprise value over EBITDA
21.941.42.79110.610
EV to operating cash flow
-161.65-6.38-52.24-132.760
EV to free cash flow
-143.13-6.36-52.24-132.760
Earnings yield
-0.08-0.080.580.060
Free cash flow yield
-0.01-0.14-0.02-0.010
Debt to equity
0.160.020.0200
Debt to assets
0.060.010.0100
Net debt to EBITDA
-0.34-0.21-0.7-10.070
Current ratio
0.250.470.675.925.91
Interest coverage
3.758.0558.62-18.670
Income quality
0.02-0.52-0.04-0.120
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.20.150.190.991.58
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
0.130000
Capex to revenue
-0.03-0.01000
Capex to depreciation
-0.23-0.06000
Stock based compensation to revenue
00000
Graham number
1.13K1.38K3.16K786.520
ROIC
0.02-0.090.1-0.01-0.01
Return on tangible assets
-0.06-0.030.140.030.01
Graham Net
-881.74-316.94-158.2449.250
Working capital
-59.77B-19.33B-8.03B11.39B10.68B
Tangible asset value
42.89B103.9B118.73B147.94B149.03B
Net current asset value
-60.7B-20.37B-8.97B9.85B8.7B
Invested capital
0.160.020.0200
Average receivables
8.95B7.39B5.67B5.35B2.59B
Average payables
497.53M388.01M384.8M357.81M127.41M
Average inventory
1.86B1.76B1.53B1.57B801.17M
Days sales outstanding
316.53211.06237.68230.130
Days payables outstanding
23.8912.5227.5915.950
Days of inventory on hand
101.4562.1292.01100.310
Receivables turnover
0.280.430.380.390
Payables turnover
3.777.193.265.640
Inventory turnover
0.891.450.980.90
ROE
-0.16-0.040.160.030.01
Capex per share
-0.99-0.31000

101140.KS Frequently Asked Questions

What is INBIOGEN CO.,Ltd stock symbol ?

INBIOGEN CO.,Ltd is a KR stock and trading under the symbol 101140.KS

What is INBIOGEN CO.,Ltd stock quote today ?

INBIOGEN CO.,Ltd stock price is $9340 today.

Is INBIOGEN CO.,Ltd stock public?

Yes, INBIOGEN CO.,Ltd is a publicly traded company.

Something similar